RecruitingNot applicableNCT05446272
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Pennsylvania
- Principal Investigator
- Elizabeth FogliaCHOP/UPENN
- Intervention
- NIV-NAVA(device)
- Enrollment
- 478 enrolled
- Eligibility
- All sexes
- Timeline
- 2022 – 2027
Study locations (20)
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- Loma Linda University, Loma Linda, California, United States
- Sharp Mary Birch, San Diego, California, United States
- Joe DiMaggio Children's Hospital, Hollywood, Florida, United States
- AdventHealth, Orlando, Florida, United States
- Peyton Manning Children's Hospital, Indianapolis, Indiana, United States
- Norton Children's Hospital, Louisville, Kentucky, United States
- Children's Mercy Hospital, Kansas City, Missouri, United States
- Washington University in St.Louis, St Louis, Missouri, United States
- Virtua Vorhees Hospital, Voorhees Township, New Jersey, United States
- Levine Children's Hospital, Charlotte, North Carolina, United States
- Atrial Health Brenner Children's Hospital( Wake Forest), Winston-Salem, North Carolina, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
- Intermountain Medical Center, Murray, Utah, United States
- +5 more locations on ClinicalTrials.gov
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05446272 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGPHASE1NCT06589245Inhaled Ciclesonide Study in Preterm InfantsVenkatesh Sampath